Arteriolosclerosis and Hypertensive Vascular Disease

Mechanical Endothelial Injury and Hemodynamic Stress

• Chronic elevated intraluminal pressure causes endothelial denudation and dysfunction, characterized by increased permeability and loss of vasodilatory capacity
• Shear stress activates NADPH oxidase and reduces nitric oxide (NO) bioavailability, creating a state of endothelial dysfunction that perpetuates vascular injury
• Loss of endothelial barrier function permits infiltration of lipoproteins and inflammatory cells into the arterial wall

Medial Smooth Muscle Cell (SMC) Response

• Sustained hypertension triggers hypertrophy and hyperplasia of medial SMCs in arterioles, a hallmark morphologic finding
• SMCs undergo phenotypic switching from contractile to synthetic phenotype, mediated by angiotensin II (Ang II), transforming growth factor-β (TGF-β), and platelet-derived growth factor (PDGF)
• Increased SMC mass contributes to increased media thickness and reduced luminal diameter, augmenting peripheral vascular resistance
• Medial SMCs deposit excessive extracellular matrix (collagen and elastin), causing arterial stiffness and reducing compliance

Renin-Angiotensin-Aldosterone System (RAAS) Activation

• Sustained hypertension paradoxically activates RAAS through baroreceptor dysfunction and renal perfusion changes
• Angiotensin II exerts vasoconstrictive effects via AT1 receptors and promotes SMC growth, migration, inflammation, and fibrosis
• Aldosterone contributes to sodium retention, volume expansion, and direct vascular inflammation and fibrosis independent of blood pressure elevation
• RAAS activation creates a self-perpetuating cycle of vasoconstriction and vascular remodeling

Oxidative Stress and Inflammation

• Hypertension increases reactive oxygen species (ROS) production through NAD(P)H oxidase, mitochondrial dysfunction, and uncoupling of endothelial NO synthase
• Excess ROS scavenges NO, reducing vasodilation and promoting peroxynitrite formation, which damages proteins and promotes inflammation
• Chronic inflammation with infiltration of macrophages and T lymphocytes into the adventitia perpetuates vascular injury and remodeling
• Pro-inflammatory mediators (TNF-α, IL-6, MCP-1) promote further endothelial dysfunction and SMC proliferation

Vascular Remodeling Mechanisms

• Eutrophic remodeling occurs early, where media thickness increases without proportional luminal enlargement, causing increased media-to-lumen ratio
• Hypertrophic remodeling represents progressive medial thickening with relative reduction in luminal diameter, increasing peripheral resistance
• In small resistance vessels, inward eutrophic remodeling is characteristic, with preserved or reduced external diameter but disproportionate luminal narrowing
• These changes occur independent of atherosclerotic plaque formation and are reversible if blood pressure control is achieved early

Molecular Signaling in Arteriolosclerosis

• TGF-β/Smad signaling promotes SMC differentiation and extracellular matrix deposition
• Mitogen-activated protein kinase (MAPK) pathways (ERK1/2) drive SMC proliferation
• Reduced AMP-activated protein kinase (AMPK) activity impairs vascular homeostasis and promotes pathologic remodeling
• Dysregulation of microRNAs (e.g., miR-21, miR-146a) contributes to sustained inflammation and SMC dysfunction

Primary (Essential) Hypertension (95% of cases)

• Polygenic inheritance with multiple loci affecting salt sensitivity, sodium-potassium ATPase function, and RAAS components
• Environmental factors: high sodium intake, obesity (particularly visceral adiposity), sedentary lifestyle, excessive alcohol consumption, and chronic stress
• Reduced nephron number from intrauterine growth restriction (Barker hypothesis) increases susceptibility

Secondary Hypertension (5% of cases)

• Renal parenchymal disease: chronic glomerulonephritis, chronic kidney disease, polycystic kidney disease (reduces sodium excretion and activates RAAS)
• Renal artery stenosis: atherosclerotic (>90% of cases) or fibromuscular dysplasia-related, causing upstream kidney hypoperfusion and RAAS activation
• Endocrine disorders: primary hyperaldosteronism (autonomous aldosterone secretion), pheochromocytoma (catecholamine excess), hyperthyroidism, Cushing syndrome
• Coarctation of aorta: mechanical obstruction causing proximal hypertension
• Medications: oral contraceptives, NSAIDs, decongestants, anabolic steroids, glucocorticoids
• Pregnancy-related: gestational hypertension, preeclampsia/eclampsia (endothelial dysfunction and placental ischemia)

Demographic and Genetic Risk Factors

• African American ancestry shows increased prevalence and severity, linked to genetic polymorphisms affecting salt sensitivity and RAAS function
• Male sex predominates in young and middle-aged individuals; female predominance after menopause
• Advanced age with loss of arterial compliance
• Family history conferring 30-40% risk in offspring

Metabolic Risk Factors

• Insulin resistance and metabolic syndrome enhance sympathetic activation and promote vascular inflammation
• Dyslipidemia, particularly elevated triglycerides and small dense LDL, perpetuates endothelial dysfunction
• Obesity increases vasoconstrictor hormones (leptin, catecholamines) and reduces vasodilatory adiponectin

Asymptomatic Phase (Often Prolonged)

• Majority of hypertensive patients are asymptomatic despite elevated blood pressure readings
• Vascular remodeling and arteriolosclerosis progress silently, detectable only through organ damage assessment
• Incidental discovery on routine blood pressure measurement or during evaluation for other conditions

Organ-Specific Manifestations Related to Hypertensive Vasculopathy

Cardiovascular Manifestations

• Angina pectoris and myocardial infarction from coronary artery involvement and demand ischemia in setting of left ventricular hypertrophy (LVH)
• Left ventricular hypertrophy (LVH) causes decreased ventricular compliance, diastolic dysfunction, and eventual systolic heart failure
• Heart failure with preserved ejection fraction (HFpEF) from concentric LVH and diastolic dysfunction
• Aortic dissection from medial degeneration (cystic medial necrosis) in ascending aorta, presenting as sudden tearing chest pain radiating to back

Cerebral Manifestations

• Ischemic stroke from lacunar infarctions and atherosclerotic disease in cerebral vessels
• Intracerebral hemorrhage from rupture of Charcot-Bouchard aneurysms in small penetrating vessels of basal ganglia, pons, and cerebellum
• Hypertensive encephalopathy with headache, confusion, seizures, and altered mental status when blood pressure exceeds cerebral autoregulation (typically >180/120 mmHg)
• Vascular dementia from progressive small vessel disease and white matter changes

Renal Manifestations

• Hypertensive nephrosclerosis with progressive proteinuria and declining GFR, manifesting as chronic kidney disease
• Acute kidney injury in setting of severe hypertension or accelerated/malignant hypertension
• Hematuria from glomerular involvement in acute hypertensive glomerulonephritis
• Nephrotic proteinuria (>3.5 g/day) in advanced hypertensive kidney disease

Ocular Manifestations (Hypertensive Retinopathy Grading)

• Keith-Wagener Grade I: arteriolar narrowing and increased arteriovenous ratio
• Grade II: arteriovenous nicking, copper wire arterioles (moderate arteriolosclerosis)
• Grade III: grade II changes plus flame hemorrhages, cotton-wool spots, hard exudates, and macular star (malignant hypertension)
• Grade IV: grade III changes plus papilledema and disk swelling (accelerated/malignant hypertension)

Acute Severe/Malignant Hypertension

• Hypertensive crisis with systolic BP >180 mmHg and/or diastolic >120 mmHg with end-organ damage
• Hypertensive urgency: severely elevated BP without acute end-organ damage
• Hypertensive emergency: severely elevated BP with acute end-organ damage (encephalopathy, acute MI, acute stroke, pulmonary edema, acute kidney injury)
• Symptoms include headache, chest pain, dyspnea, altered mental status, and visual disturbances

Physical Examination Findings

• Elevated blood pressure on repeated measurements (diagnostic threshold ≥130/80 mmHg in current guidelines)
• Displaced apical impulse (lateralized and downward) indicating LVH
• S4 gallop from reduced ventricular compliance and forceful atrial contraction
• Retinal changes on fundoscopy ranging from arteriovenous nicking to papilledema
• Diminished peripheral pulses and asymmetric blood pressures if renal artery stenosis present

Laboratory and Imaging Correlates

• Left ventricular hypertrophy on electrocardiography (increased voltage criteria, strain pattern with ST depression and T-wave inversion in lateral leads)
• Concentric LVH on echocardiography with increased wall thickness, reduced chamber size, and diastolic dysfunction
• Elevated creatinine and reduced GFR reflecting renal arteriolosclerosis
• Proteinuria (often in range of 100-500 mg/day, but can be nephrotic)
• Hematuria in acute hypertensive glomerulonephritis or malignant hypertension

Clinical Diagnosis of Hypertension

• Diagnosis requires elevated blood pressure on ≥2 separate occasions, excluding "white coat" hypertension by out-of-office measurements (home or ambulatory monitoring)
• Current guideline definition: systolic ≥130 mmHg and/or diastolic ≥80 mmHg (American College of Cardiology/American Heart Association 2017 guidelines)
• Stage 1 hypertension: 130-139 mmHg systolic or 80-89 mmHg diastolic
• Stage 2 hypertension: ≥140 mmHg systolic or ≥90 mmHg diastolic

Assessment of End-Organ Damage

• Electrocardiography: assess for LVH (Sokolow-Lyon criteria, Cornell voltage), strain pattern, and ischemic changes
• Echocardiography: gold standard for evaluating LVH severity, wall thickness, relative wall thickness [(2×posterior wall thickness)/LV end-diastolic diameter], and systolic/diastolic function
• Renal function panel: serum creatinine, calculated GFR, blood urea nitrogen to assess hypertensive nephrosclerosis
• Urinalysis: assess for proteinuria and hematuria
• Fundoscopic examination: grade hypertensive retinopathy severity

Histological Findings (When Tissue Obtained)

Arteriolosclerosis (Hyaline Arteriolosclerosis)

• Homogeneous, glassy eosinophilic thickening of arteriolar walls under light microscopy
• Loss of normal medial architecture with replacement by hyaline material (basement membrane material, plasma proteins, and collagen)
• Narrowed luminal diameter relative to wall thickness (increased media-to-lumen ratio)
• Smooth muscle cell dropout in medial layer with nuclear pyknosis
• Immunofluorescence shows basement membrane proteins (collagen IV, laminin) in the thickened wall
• Electron microscopy reveals basement membrane reduplication and smooth muscle cell degeneration

Acute Hypertensive Arteriolitis (Malignant Hypertension)

• Acute necrosis of arteriolar walls (acute arteriolitis or acute arterial necrosis)
• Fibrinoid necrosis with fibrin deposition and loss of normal wall architecture
• Acute infiltrate of neutrophils and mononuclear cells with prominent vasculitis pattern
• Contrasts sharply with chronic hyaline arteriolosclerosis's bland appearance
• May show red blood cell extravasation and hemorrhage into vessel wall

Hypertensive Glomerulonephritis (in Malignant Hypertension)

• Acute proliferative glomerulonephritis with endocapillary proliferation of mesangial and endothelial cells
• Crescent formation (fibrocellular crescents) in severe cases
• Fibrinoid necrosis of capillary loops and mesangium
• Immunofluorescence shows fibrinogen deposition (fibrinoid necrosis) and complement C3

Gross Pathology Findings

• Kidney: granular surface appearance with petechial hemorrhages ("flea-bitten kidney") in acute malignant hypertension; chronic cases show granular atrophy from arteriolosclerosis
• Brain: acute intracerebral hemorrhages in basal ganglia, pons, or cerebellum; chronic changes of small vessel disease and lacunar infarcts
• Heart: enlarged, heavy heart with concentric LVH; dilated left ventricle if progression to systolic dysfunction
• Aorta: atherosclerotic plaques and potential dissection with medial degeneration

Imaging Studies for Secondary Hypertension Evaluation

• Renal artery duplex ultrasound or CT/MR angiography: screen for renal artery stenosis if clinical suspicion high
• Abdominal imaging: assess kidney size and symmetry; small kidneys suggest chronic parenchymal disease
• Plasma renin activity and aldosterone levels: screen for primary hyperaldosteronism if hypokalemia present
• 24-hour urine catecholamines and plasma metanephrines: screen for pheochromocytoma if paroxysmal symptoms
• TSH and free T4: screen for thyroid disorders contributing to secondary hypertension

Diagnostic Criteria for Hypertensive Urgency vs. Emergency

• Hypertensive urgency: SBP >180 mmHg or DBP >120 mmHg WITHOUT acute end-organ damage
• Hypertensive emergency (crisis): SBP >180 mmHg or DBP >120 mmHg WITH acute end-organ damage (encephalopathy, acute coronary syndrome, acute heart failure with pulmonary edema, acute stroke, aortic dissection, acute kidney injury, eclampsia, or retinopathy with papilledema)

First-Line Antihypertensive Agents (for Chronic Hypertension Management)

ACE Inhibitors and Angiotensin II Receptor Blockers (ARBs)

• Mechanism: block RAAS activation, reducing vasoconstriction and aldosterone-mediated sodium retention; prevent Ang II-mediated SMC growth and inflammation
• Rationale for first-line use: reduce proteinuria, slow progression of chronic kidney disease, prevent LVH, reduce cardiovascular events
• Agents: lisinopril, enalapril (ACE inhibitors); losartan, valsartan (ARBs)
• Caution: monitor potassium and creatinine; contraindicated in pregnancy (teratogenic)
• Advantages: organ-protective effects beyond blood pressure

Vascular/end-organ complications of the disease

• Intracerebral hemorrhage (emergency): rupture of Charcot-Bouchard microaneurysms in lipohyalinized penetrating arteries; signaled by sudden focal deficit with headache/vomiting and hyperdense blood in the basal ganglia (putamen), thalamus, pons, or cerebellum on noncontrast CT. Distinguish from berry aneurysm rupture, which is subarachnoid.
• Lacunar infarction and vascular cognitive impairment: occlusion of the same small penetrators by hyaline thickening; pure motor hemiparesis (internal capsule) or pure sensory stroke (thalamus), with confluent white matter change on MRI.
• Hypertensive encephalopathy / PRES (emergency): breakthrough of cerebral autoregulation → vasogenic edema; headache, seizures, altered mentation with posterior (parieto-occipital) white matter edema on MRI, reversible with BP control.
• Aortic dissection (emergency): medial degeneration under pulsatile stress; tearing chest/back pain, pulse or BP differential, widened mediastinum.
• Flash pulmonary edema and HFpEF decompensation (emergency when hypoxemic): afterload mismatch on a stiff hypertrophied ventricle.
• Nephrosclerosis progressing to ESRD: ischemic glomerular sclerosis behind narrowed afferent arterioles; rising creatinine with modest proteinuria and small, granular "grain-leather" kidneys.
• Malignant hypertension with thrombotic microangiopathy (emergency): fibrinoid necrosis and hyperplastic onion-skin arteriolosclerosis → mechanical red cell shear; schistocytes, anemia, thrombocytopenia, LDH elevation, AKI, papilledema, and a flea-bitten kidney at autopsy.

Complications of treatment

• Excessive BP lowering: watershed infarction and coronary/renal hypoperfusion because chronic hypertension shifts the autoregulatory curve rightward. ACC/AHA guidance for most hypertensive emergencies is a controlled reduction of mean arterial pressure by roughly a quarter in the first hour, then gradual normalization — exceptions are aortic dissection (rapid lowering with an IV beta blocker before any vasodilator) and thrombolysis-eligible stroke, where AHA/ASA sets a pre-tPA ceiling.
• RAAS blockade: hyperkalemia, angioedema, cough, and functional AKI when GFR depends on efferent tone (bilateral renal artery stenosis, volume depletion); ACE inhibitors and ARBs are contraindicated in pregnancy.
• Thiazides: hyponatremia, hypokalemia, hyperuricemia. Nitroprusside: cyanide/thiocyanate toxicity with prolonged infusion or renal failure. Hydralazine: reflex tachycardia and drug-induced lupus.

• Two morphologies, two settings: hyaline arteriolosclerosis = homogeneous pink glassy wall thickening from plasma protein leak and basement membrane material — seen in long-standing benign hypertension and diabetes mellitus. Hyperplastic arteriolosclerosis = concentric laminated smooth muscle and reduplicated basement membrane, the onion-skin appearance, often with fibrinoid necrosis — seen in malignant hypertension.
• The association examiners love: onion-skinning plus fibrinoid necrosis → malignant hypertension or scleroderma renal crisis. For scleroderma renal crisis the single best next step is an ACE inhibitor (captopril is favored for rapid titration because of its short half-life), continued even as creatinine rises; it is contraindicated in pregnancy, as are all ACE inhibitors.
• Diabetic twist: hyaline change involves both afferent and efferent arterioles; efferent narrowing raises intraglomerular pressure and drives hyperfiltration, the rationale for RAAS blockade in albuminuric diabetic kidney disease per KDIGO and the ADA Standards of Care.
• Gross buzzwords: flea-bitten kidney (petechiae of malignant hypertension) versus finely granular, contracted kidneys of chronic benign nephrosclerosis.
• Single best next step in a hypertensive crisis: decide emergency versus urgency by looking for acute end-organ injury (fundoscopy, neuro exam, troponin, creatinine, urinalysis, CT if focal deficit). Emergency → titratable IV agent (nicardipine, labetalol; esmolol plus a vasodilator for dissection) with graded lowering per ACC/AHA; urgency → oral agent and prompt follow-up, not aggressive IV therapy.
• Common distractor: Mönckeberg medial calcific sclerosis — calcification of the media of medium muscular arteries, radiographically striking but does not narrow the lumen and is not hypertension-related. Do not confuse it with arteriolosclerosis or with atherosclerosis (intimal, large/medium arteries).
• Second distractor: hypertensive intracerebral hemorrhage arises from Charcot-Bouchard microaneurysms in deep structures; lobar hemorrhage in an elderly normotensive patient suggests cerebral amyloid angiopathy instead.